focus -WSS

focus

author：focus 2025-08-11 16:24:23 - browse：473

Sammy Kimball for STAT

Can Novavax finally get it right? What’s a “triple-G” drug? And is Novo Nordisk losing ground?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Elaine Chen joins us to explain how the era of Wegovy could be short-lived in light of powerful new weight-loss medicines from Eli Lilly. Then, John Jacobs, the new CEO of Novavax, stops by to explain his plan to right the ship at a company that has struggled to make the most of its potent Covid-19 vaccine.

For more on what we cover, here’s the news on Lilly; here’s more on Novavax; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Sports medicine is finally prioritizing gender equality
Next article： Padmanee Sharma of MD Anderson at center of lawsuit over credit

leisure time

WSS

Updated Covid vaccine has 54% effectiveness, new study suggests

Russian fighter jet damages US Reaper drone with flare over Syria: Officials

What it's like to live with paralysis for one psychologist

Biogen says it will cut costs by $700 million, slash 1,000 jobs

The CDC's new social media misinformation war

Vyjuvek, a gene therapy for skin wounds, restored vision in one boy

entertainment

focus

hotspot

New air purifier tech could be key to improving indoor air quality

'Investigate these claims': UFO transparency at center of House hearing

Alkermes shareholders re

UHS says company favors patients whose insurance pays more

Hepatitis C has a cure — but many Americans still lack access to it

A single Democrat is willing to weaken Medicare negotiation power

Medical leaders decry Supreme Court decision on affirmative action

AstraZeneca stays mum on Medicare drug pricing negotiations

Heart attack and stroke risk calculators need revising

Problems with a popular proposal to regulate AI in health care

focus

Global cancer cases to surge 77% by 2050, WHO report says

Senate panel puts off hardest PBM reforms for another day

Devoted Health’s losses in Medicare Advantage persist

Senate panel puts off hardest PBM reforms for another day

Will the FTC rein in IQVIA's health data empire?

Gene therapy for Afghan refugees’ infant will be fully covered

leisure time

leisure time

focus

entertainment